Ribon Therapeutics Announces License Agreement with Ono Pharmaceutical Co., Ltd. to Develop and Commercialize RBN-2397 In Japan, South Korea, Taiwan and ASEAN Countries
Cookies are used on our website. Press Accept if you consent to the use of cookies, press Decline if you do not consent to the use of cookies.AcceptDecline